Eyewire Today


Local ROCK Inhibition Highly Effective in Lowering IOP in Glaucoma Model While Avoiding Hyperemia

From Amakem NV

Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held at Fort Lauderdale. The ARVO meeting is the worlds largest gathering of international eye a...

Login to read story

Monday, July 28, 2014

Show last days of articles

Alphaeon Acquires PRN Specialty Nutriceutical Company

From Alphaeon Corp. — 7/28/2014

Alphaeon Corp., a subsidiary of Strathspey Crown Holdings LLC, announced that it has acquired Physician Recommended Nutriceuticals (PRN...Full story

Deadline to Check Industry Payments to Docs Fast Approaching

From Medscape Ophthalmology — 7/28/2014

Physicians have until August 27 to review and challenge what drug and device makers have reported giving to them by way of cash or gifts as part of th...Full story

Medicare Pressed to Bargain on Drug Costs

From Medpage Today — 7/28/2014

Medicare could save billions if Congress overcame its reluctance to anger the drug industry and allowed the program to demand rebates or negotiate pri...Full story

New Treatments On the Horizon to Treat Inherited Retinal Dis...

From Medical News Today — 7/28/2014

The National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with Fight for Sight, has identified 40 potential new treatme...Full story

Friday, July 25, 2014

I-Optics Announces New Cassini Total Corneal Astigmatism Fun...

From i-Optics — 7/25/2014

I-Optics will be launching new functionality for its Cassini corneal shape analyzer that will allow it to measure both anterior and posterior astigmat...Full story

Singapore Team Develops Asia's First Genetic Test That Can P...

From Medical Xpress — 7/25/2014

A team of eye doctors and scientists from Singapore have developed Asia's first genetic test for identifying patients with a type of eye disease that ...Full story

Robert E. Marc Named Recipient of 2014 Paul Kayser Internati...

From News-Medical — 7/25/2014

Robert E. Marc, PhD, director of research at the University of Utah's John A. Moran Eye Center, has been named by the International Society of Eye Res...Full story

Allergan Announces Ozurdex Receives European Positive Opinio...

From Allergan — 7/25/2014

Allergan announced that the European Unions Committee for Medicinal Products for Human Use (CHMP) has recommended extending the marketing authorizatio...Full story

TNF Inhibitor Therapy Effective for Behcet's Disease Uveitis

From Medscape Ophthalmology — 7/25/2014

When uveitis due to Behcet's disease fails to respond to conventional therapy, anti-TNF-alpha therapy may help, according to a Spanish study. Anti-TNF...Full story

Ocular Therapeutix Prices Initial Public Offering

From Ocular Therapeutix — 7/25/2014

Ocular Therapeutix announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $13 per ...Full story

Tumor Growth and Metastasis Controlled by New Drug Combo in ...

From Medical News Today — 7/25/2014

Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and me...Full story

More Years of School Correspond to More Nearsightedness

From Medscape Ophthalmology — 7/25/2014

More education was associated with a higher prevalence of nearsightedness in a study of more than 4500 people, and myopia worsened with additional yea...Full story

Thursday, July 24, 2014

Oculus Corvis ST in Microgravity

From Oculus — 7/24/2014

NASA made successful use of the Corvis ST high-speed Scheimpflug camera during two parabolic flights on June 5-6 in Houston, Texas, according to a com...Full story

Aerie Pharmaceuticals Receives Health Canada "No Objection L...

From Aerie Pharmaceuticals — 7/24/2014

Aerie Pharmaceuticals announced that it has received a "No Objection Letter" from Health Canada to conduct a phase 3 registration trial of Rhopressa, ...Full story

Immune Response Damaging in Acute Glaucoma

From Medical News Today — 7/24/2014

Researchers at the University of California, San Diego School of Medicine and Sun Yat-sen University in China have shown that acute glaucoma in mice i...Full story

Imprimis Pharmaceuticals' Go Dropless Cataract Surgery Formu...

From Imprimis Pharmaceuticals Inc. — 7/24/2014

Imprimis Pharmaceuticals, Inc. announced that two key opinion leader presentations that describe the benefits of dropless cataract surgery formulation...Full story

Could Eye and Smell Tests Offer Early Alzheimer's Diagnosis?

From Medical News Today — 7/24/2014

In the US, someone is diagnosed with Alzheimer's disease every 67 seconds. Current clinical diagnostic tests mean the disease can only be detected in ...Full story

Wednesday, July 23, 2014

TrueVision Granted Fundamental Patent on Real-Time Surgical ...

From TrueVision 3D Surgical — 7/23/2014

TrueVision 3D Surgical announced it has been issued a patent by the U.S. Patent & Trademark Office for fundamental technology underlying computer ...Full story

American Academy of Optometry Announces 2014 Award Recipient...

From American Academy of Optometry — 7/23/2014

The American Academy of Optometry has announced its 2014 award recipients. Award winners will be recognized at the Academy 2014 Denver Awards Ceremony...Full story

Appeals Courts Rule Opposite Ways on ACA Subsidies

From Medpage Today — 7/23/2014

Opposing rulings by two federal appeals courts Tuesday on the legality of subsidies for people purchasing insurance through the Affordable Care Act's ...Full story

FDA Issues Informed Consent Guidance for Clinical Trials

From Medpage Today — 7/23/2014

The FDA recently issued an updated guidance document on obtaining informed consent for clinical trials, but little has changed that would affect enrol...Full story

PowerVision Appoints Douglas D. Koch, MD, to its Scientific ...

From PowerVision Inc. — 7/23/2014

PowerVision, Inc. announced that Douglas D. Koch, MD, the Allen, Mosbacher, and Law Chair of Ophthalmology, and Professor of Ophthalmology, at Baylor ...Full story

Animal Study of Cellular Stress in Degenerative Illnesses Fi...

From Medical News Today — 7/23/2014

In a new study led by UC San Francisco (UCSF) scientists, a chemical compound designed to precisely target part of a crucial cellular quality-control ...Full story


Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...